You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 7, April 13, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Secondary Causes of Resistant Hypertension

Weekitt Kittisupamongkol, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I read with interest the article by Salles and colleagues.1 While suboptimal therapy is the most common cause of resistant hypertension, secondary hypertension contributes up to 10% of hypertension referrals.2 In this recent article by Salles et al1 and in previous publications from this cohort, it is not mentioned whether secondary causes of hypertension were excluded. Furthermore, it is well known that patients with secondary causes of hypertension often have not only nocturnal hypertension but also excess cardiovascular morbidity and mortality, which could be related to secondary hypertension.3 If patients with secondary causes of hypertension were not excluded, it is possible that the relationship between nocturnal hypertension and cardiovascular outcomes could be confounded by metabolic and other processes associated with secondary hypertension, such as hyperaldosteronism, elevated angiotensin II level, diabetes, or renal dysfunction.


AUTHOR INFORMATION
Correspondence: Dr Kittisupamongkol, Department of Medicine, Hua Chiew Hospital, 665 Bumrungmuang Rd, Bangkok 10100, . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant Hypertension
Gil F. Salles, Claudia R. L. Cardoso, and Elizabeth S. Muxfeldt
Arch Intern Med. 2008;168(21):2340-2346.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.